For 125 years, Blatchford have been designing and manufacturing pioneering prosthetic and orthotic products
Blatchford is a world leading rehabilitation provider with clinical expertise in prosthetics, orthotics, special seating and wheelchairs. They specialise in prosthetic and orthotic products based on bio-mimetic design principles that work in sync with the human body. Their technology is designed to help individuals achieve the best possible mobility, function, comfort and long-term outcomes following amputation or other pathology.
Headquartered in the United Kingdom, Blatchford has offices throughout the world including the US, Norway, Russia, Turkey and Germany. Blatchford provides clinical services to the NHS and Military, as well as to private patients both in the UK and internationally.
The company was established in 1890 and has since become an innovator in its field, recently launching the Linx, the first microprocessor-controlled lower limb system where the foot and knee continuously talk to each other to optimise performance and improve safety.
Blatchford is also known for their award-winning the Endolite Carbon Fibre System and range of lower limb prostheses that have set industry standards.
At the forefront of innovation
Blatchford’s innovations over the years have made breakthroughs in the world of prosthetic technology:
- The IP knee in the 1990s, which was the first commercial microprocessor-controlled knee.
- Elan in 2012, the first microprocessor-controlled hydraulic ankle
- Linx in 2016, the world’s first fully integrated above knee prosthesis, which was awarded the UK’s premier engineering prize and the Royal Academy of Engineering’s MacRobert Award
Recently, Professor Mir Saeed Zahedi OBE, Blatchford's Technical Director, received a Knighthood for his outstanding services to Innovation and Engineering in the field of rehabilitation.
Adrian Stenson, CEO of Blatchford said: "At Blatchford, we are constantly striving to provide innovative prosthetic technology to help improve the day-to-day lives of patients that are faced with limb loss."